CWBHF · Charlotte's Web Holdings, Inc.
Market Cap
$80.03M
Shares
271.29M
CWBHF metrics
59 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.31
Market cap
$80.03M
Price action
19 metricsPrice change (1W)
-8.5%
Price change (30D)
+31.8%
Price change (3M)
-36.7%
Price change (6M)
-58.0%
Price change (YTD)
-15.3%
Price change (1Y)
+220.6%
Trailing year
Price change (5Y)
-86.9%
52-week high
$0.92
52-week low
$0.09
Change from 52-week high
-66.2%
Change from 52-week low
+265.9%
Annualized volatility
150.2%
Beta
1.0
RSI (14D)
53.8
Price vs SMA 50
+9.7%
Price vs SMA 200
-26.4%
Avg volume (3M)
294,251
Relative volume
0.1
Average dollar volume
$90,505
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
271.29M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 58.5%
P / book
1.4
reciprocal yield 70.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-43.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-13
Profitability
9 metricsGross margin
42.4%
Operating margin
-41.7%
Trailing 12 months
Net margin
-73.6%
Gross profit (TTM)
$19.84M
Operating profit (TTM)
−$19.53M
Net income (TTM)
−$34.48M
Trailing 12 months
Diluted EPS (TTM)
$-0.21
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-15.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$46.84M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+25.3%
Year over year · more shares
Revenue CAGR (3Y)
-12.4%
Revenue CAGR (5Y)
-12.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-61.5%
Return on assets
-45.1%
Debt / equity
—
Current ratio
4.2
EBITDA (TTM)
−$13.00M
Free cash flow (TTM)
—
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.99M
Latest balance sheet
Cash & equivalents
$13.99M
Total assets
$76.39M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$11.04M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$39.37M
Stock compensation (TTM)
$954,000
R&D / revenue
—
Stock compensation / revenue
2.0%
Ownership (13F)
3 metrics13F filers
3
13F filer change QoQ
-1
Institutional ownership
0.0%
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
24 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—